Neoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: A phase 2 trial

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Neoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: A phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences